- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01790776
Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA) (SONO-URETHRA)
Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography: Evaluation of the Diagnostic Value and Evaluation of the Reduction of the Radiation Dose With Sono-urethrography (SONO-URETHRA)
Conventional urethrography is the standard diagnostic evaluation for patients with a suspicion of urethral stricture. The radiation dose of this examination is 5-9 mSV. Sono-urethrography was introduced in 1988 (McAninch et al. , J Urol 1988); the diagnostic accuracy of sono-urethrography is equal compared to conventional urethrography, with even a better measurement of stricture length and degree of spongiofibrosis with sono-urethrography. However, sono-urethrography remained underused among urologists and radiologists.
Patients will be randomly assigned into two groups:
Group A: conventional urethrography Group B: sono-urethrography In case sono-urethrography is inconclusive or of poor quality, a conventional urethrography will be performed.
The radiation dose in the two groups will be measured. The stricture length and location will be recorded and compared with the perioperative findings in order to evaluate the diagnostic accuracy. The complications of the procedure(s) will be recorded with a questionnaire directly after and two weeks after the conventional or sono-urethrography.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Ghent, Belgium, 9000
- Ghent University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with a suspicion of urethral stricture disease for which an indication of imaging of the urethra exists.
Exclusion Criteria:
- Transsexual patients.
- Patients with perineostomy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional urethrography
Current golden standard.
|
Urografin 30% (Natrium amidotrizoas 10G, Megalumin, Amidotrizoas 65G, Natrii calcii edetas, water for injection 250 ml, with 146 mg iodium/ml). The tip of a bladder catheter is placed at the external urethral meatus and fixed at this location. The solution (urografin 30 %) is instilled. |
Experimental: Sono-urethrography
Experimental urethrography, which could be followed by conventional urethrography if the results are inconclusive.
|
The tip of a bladder catheter is placed at the external urethral meatus and fixed at this location.
The solution (NaCl 0,9 % in aqua) is instilled.
If the result is inconclusive, urografin 30 % will be instilled.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Radiation dose during diagnostic intervention.
Time Frame: During urethrography.
|
The radiation dose will be measured with a dosimeter.
|
During urethrography.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic accuracy of sono-urethrography vs conventional urethrography.
Time Frame: Immediately and 2 weeks after urethrography
|
The results of sono-urethrography and conventional urethrography will be compared with the intraoperative situation (place stricture, length stricture); contrast allergy and complications are scored with a questionnaire.
|
Immediately and 2 weeks after urethrography
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicolaas Lumen, M.D., Ph.D., University Hospital, Ghent
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/902
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urethral Stricture Disease
-
Urotronic Inc.WithdrawnLower Urinary Tract Symptoms | Urethral Stricture | Urethral Stricture, Anterior | Anterior Urethral Stricture
-
University of California, San FranciscoRecruitingUrethral Stricture, MaleUnited States
-
University Hospital, GhentCompletedAnterior Urethral Stricture, MaleBelgium
-
Lepu Medical Technology (Beijing) Co., Ltd.Recruiting
-
University Hospital Virgen de las NievesInstituto de Investigación Biosanitaria de Granada (ibs.Granada)RecruitingFibrosis | Hormone Deficiency | Urethral Stricture, MaleSpain
-
Al-Azhar UniversityCompleted
-
Ain Shams UniversityCompletedUrethral Stricture, MaleEgypt
-
Regenosca SARecruiting
-
Ain Shams UniversityCompletedUrethral StrictureEgypt
Clinical Trials on Urografin 30%
-
Hvidovre University HospitalCompletedCholecystitis | Gallstones
-
Mayo ClinicCompleted
-
Chang Gung Memorial HospitalCompleted
-
National Yang Ming UniversityCompletedTranscranial Magnetic Stimulation | Non-specific Chronic Neck Pain | Neuromuscular Control | Office WorkersTaiwan
-
University of Texas at AustinCompleted
-
Rush University Medical CenterWithdrawnChronic Low-back Pain | Peripheral Neuropathy | CRPS
-
University Malaysia SarawakUniversity of MalayaCompleted
-
Institut Rosell LallemandCompleted
-
Cartesian TherapeuticsRecruitingCovid19 | Acute Respiratory Distress SyndromeUnited States
-
University of MiamiSjogrens Syndrome Foundation; Microbiome Health Research InstituteCompleted